Literature DB >> 15761850

Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma.

Angela S Archambault1, Julia Sim, Mary Ann T Gimenez, John H Russell.   

Abstract

In experimental autoimmune encephalomyelitis (EAE), intravenous transfer of activated CD4(+) myelin-specific T cells is sufficient to induce disease. Transferred T cells access the CNS parenchyma by trafficking across the blood brain barrier (BBB) vascular endothelium into the perivascular space, and then across the glial limitans that is made up of astrocytes and microglia. Flow cytometry analysis of cells isolated from CNS tissue does not distinguish between T cell populations at the various stages of migration. In this study, we have used GK1.5 (anti-CD4) treatment along with immunohistochemistry to distinguish between populations of T cells that are associated with the vasculature, T cells that have migrated into the perivascular space, and T cells in the parenchyma. We have also re-evaluated antigen specificity requirements of T cells as they are recruited to the CNS parenchyma. Activated myelin-specific T cells are restricted to the CNS vasculature for at least 24 h post transfer. MHC class II expression on the recipient is required for cells to traffic across the CNS vascular endothelium. Further, Con A-stimulated or non-CNS-specific (ovalbumin-specific) T cells fail to migrate into the perivascular space, and only enter the CNS parenchyma when co-transferred with myelin-specific T cells. Our results indicate that Th1 populations cannot accumulate in the perivascular (subarachnoid, Virchow-Robbins) space without a CNS antigen-specific signal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761850     DOI: 10.1002/eji.200425864

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

Review 1.  T-cells in Alzheimer's disease.

Authors:  Terrence Town; Jun Tan; Richard A Flavell; Mike Mullan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 2.  Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

Authors:  Burkhard Becher; Ingo Bechmann; Melanie Greter
Journal:  J Mol Med (Berl)       Date:  2006-06-14       Impact factor: 4.599

Review 3.  Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity.

Authors:  Ari Waisman; Lisa Johann
Journal:  J Mol Med (Berl)       Date:  2018-11-01       Impact factor: 4.599

4.  In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.

Authors:  Jinguo Wang; Sue Tsai; Afshin Shameli; Jun Yamanouchi; Gonnie Alkemade; Pere Santamaria
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 5.  T cells in the central nervous system: messengers of destruction or purveyors of protection?

Authors:  James T Walsh; Nikki Watson; Jonathan Kipnis
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

6.  B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.

Authors:  Chelsea R Parker Harp; Angela S Archambault; Julia Sim; Stephen T Ferris; Robert J Mikesell; Pandelakis A Koni; Michiko Shimoda; Christopher Linington; John H Russell; Gregory F Wu
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

7.  A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord.

Authors:  Mary Ann Gimenez; Julia Sim; Angela S Archambault; Robyn S Klein; John H Russell
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

8.  Odorants specifically modulate chemotaxis and tissue retention of CD4+ T cells via cyclic adenosine monophosphate induction.

Authors:  Adam A Clark; Saule Nurmukhambetova; Xin Li; Steven D Munger; Jason R Lees
Journal:  J Leukoc Biol       Date:  2016-05-06       Impact factor: 4.962

Review 9.  CD4 T cells in immunity and immunotherapy of Alzheimer's disease.

Authors:  Alon Monsonego; Anna Nemirovsky; Idan Harpaz
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

10.  Regulation of vacuolar H(+)-ATPase in microglia by RANKL.

Authors:  Eric M Serrano; Ryan D Ricofort; Jian Zuo; Noelle Ochotny; Morris F Manolson; L Shannon Holliday
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.